Literature DB >> 28497309

The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis.

Sen Jiang1, Hua Gao2, Qin Luo3, Pengfei Wang1, Xinling Yang4.   

Abstract

The correlation between immunity and Parkinson's disease was presented in many papers, which also discussed lymphocyte and natural killer cell. But these studies have yielded inconsistent results. To systematically review the relationship between the lymphocyte subsets/natural killer cell and the risk of Parkinson's disease, we electronically searched the SpringerLink, Web of Science, Ebsco-medline with full text, Pubmed, Elsevier-ScienceDirect, Ovid-lww-oup, Wanfang Data for case-control trials on comparing the number of peripheral blood lymphocyte subsets and natural killer cell in Parkinson's patients and healthy controls. According to the Cochrane methods, the reviewers selected literature, extracted data, and assessed the quality. Then, a meta-analysis was performed using RevMan 5.2. Finally, 21 case-control trials including 943 cases of Parkinson's disease were fit into our data analysis. Meta-analysis showed that the decreased numbers of CD3+, CD4+ lymphocyte subsets and the increased number of natural killer cell were found in Parkinson's disease patients. In the intermediate and late stage of PD, CD8+ lymphocyte subsets had a significant decrement. However, the number of B lymphocyte subsets had no significant association with Parkinson's disease. The lymphocyte subsets and NK cell may be associated with the risk of Parkinson's disease.

Entities:  

Keywords:  Case-control trial; Lymphocyte subsets; Meta-analysis; NK cell; Parkinson’s disease; Systematic review

Mesh:

Year:  2017        PMID: 28497309     DOI: 10.1007/s10072-017-2988-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

2.  [Clinical analysis of subpopulation of peripheral T and B lymphocytes in Chinese Parkinson's disease patients].

Authors:  Siyun Zhang; Congcong Sun; Limin Zhang; Luan Cen; Mingshu Mo; Zhuolin Liu; Wei Huang; Feiqi Zhu; Ping Kang; Zhaojun Chen; Li Yi; Pingyi Xu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2014-12-23

3.  Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease.

Authors:  Fumitoshi Niwa; Nagato Kuriyama; Masanori Nakagawa; Jiro Imanishi
Journal:  Geriatr Gerontol Int       Date:  2011-09-19       Impact factor: 2.730

4.  Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease.

Authors:  K Hisanaga; M Asagi; Y Itoyama; Y Iwasaki
Journal:  Arch Neurol       Date:  2001-10

Review 5.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

6.  Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.

Authors:  Natalia Pessoa Rocha; Frankcinéia Assis; Paula Luciana Scalzo; Érica Leandro Marciano Vieira; Izabela Guimarães Barbosa; Mariana Soares de Souza; Paulo Pereira Christo; Helton José Reis; Antonio Lucio Teixeira
Journal:  Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.590

7.  A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson's disease.

Authors:  S Chiba; H Matsumoto; M Saitoh; M Kasahara; M Matsuya; M Kashiwagi
Journal:  J Neurol Sci       Date:  1995-10       Impact factor: 3.181

8.  Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease.

Authors:  Suraj Pradhan; Katrin Andreasson
Journal:  Exp Neurol       Date:  2012-12-21       Impact factor: 5.330

Review 9.  Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis.

Authors:  Chuanwei Li; Wen Zhang; Faying Zhou; Caiyu Chen; Liang Zhou; Yafei Li; Ling Liu; Fang Pei; Hao Luo; Zhangxue Hu; Jing Cai; Chunyu Zeng
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.240

10.  Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Authors:  Eric J Benner; Rebecca Banerjee; Ashley D Reynolds; Simon Sherman; Vladimir M Pisarev; Vladislav Tsiperson; Craig Nemachek; Pawel Ciborowski; Serge Przedborski; R Lee Mosley; Howard E Gendelman
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  34 in total

1.  Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.

Authors:  Kirsten M Anderson; Danillo G Augusto; Ravi Dandekar; Hengameh Shams; Chao Zhao; Tasneem Yusufali; Gonzalo Montero-Martín; Wesley M Marin; Neda Nemat-Gorgani; Lisa E Creary; Stacy Caillier; Mohammad R K Mofrad; Peter Parham; Marcelo Fernández-Viña; Jorge R Oksenberg; Paul J Norman; Jill A Hollenbach
Journal:  J Immunol       Date:  2020-07-24       Impact factor: 5.422

2.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

Review 3.  Therapeutic Strategies for Immune Transformation in Parkinson's Disease.

Authors:  Maamoon Saleh; Milica Markovic; Katherine E Olson; Howard E Gendelman; R Lee Mosley
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies.

Authors:  Miriam Højholt Terkelsen; Ida H Klaestrup; Victor Hvingelby; Johanne Lauritsen; Nicola Pavese; Marina Romero-Ramos
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Abnormal subpopulations of peripheral blood lymphocytes are involved in Parkinson's disease.

Authors:  Congcong Sun; Zhenxiang Zhao; Wenfei Yu; Mingshu Mo; Chengyuan Song; Youfeng Si; Yiming Liu
Journal:  Ann Transl Med       Date:  2019-11

6.  Evidence for Peripheral Immune Activation in Parkinson's Disease.

Authors:  Xueping Chen; Weihua Feng; Ruwei Ou; Jiao Liu; Jing Yang; Jiajia Fu; Bei Cao; Yongping Chen; Qianqian Wei; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2021-04-30       Impact factor: 5.750

7.  Lower Circulating Lymphocyte Count Predicts ApoE ε4-Related Cognitive Decline in Parkinson's Disease.

Authors:  Kazuto Tsukita; Haruhi Sakamaki-Tsukita; Ryosuke Takahashi
Journal:  Mov Disord       Date:  2021-10-13       Impact factor: 9.698

8.  Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease.

Authors:  Elena Contaldi; Luca Magistrelli; Anna Vera Milner; Marco Cosentino; Franca Marino; Cristoforo Comi
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 9.  Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk.

Authors:  Austin P Passaro; Abraham L Lebos; Yao Yao; Steven L Stice
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

10.  Dysregulation of the Adaptive Immune System in Patients With Early-Stage Parkinson Disease.

Authors:  Zhaoqi Yan; Wei Yang; Hairong Wei; Marissa N Dean; David G Standaert; Gary R Cutter; Etty N Benveniste; Hongwei Qin
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.